GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000105) » Definitions » Other Net Income (Loss)

Yuhan (XKRX:000105) Other Net Income (Loss) : ₩0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1962. Start your Free Trial

What is Yuhan Other Net Income (Loss)?

Yuhan's Other Net Income (Loss) for the three months ended in Mar. 2024 was ₩0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩0 Mil.

Yuhan's quarterly Other Net Income (Loss) declined from Sep. 2023 (₩0 Mil) to Dec. 2023 (₩0 Mil) but then stayed the same from Dec. 2023 (₩0 Mil) to Mar. 2024 (₩0 Mil).

Yuhan's annual Other Net Income (Loss) declined from Dec. 2021 (₩0 Mil) to Dec. 2022 (₩0 Mil) and declined from Dec. 2022 (₩0 Mil) to Dec. 2023 (₩-0 Mil).


Yuhan Other Net Income (Loss) Historical Data

The historical data trend for Yuhan's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuhan Other Net Income (Loss) Chart

Yuhan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Yuhan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Yuhan Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yuhan Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Yuhan's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Yuhan (XKRX:000105) Business Description

Traded in Other Exchanges
Address
74, Noryangjin-ro, Dongjak-gu, Seoul, KOR
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplement, household and animal care, and contract manufacturing of active pharmaceutical ingredients. Yuhan offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.

Yuhan (XKRX:000105) Headlines

No Headlines